Abstract
A predisposing gene for breast and ovarian cancer has recently been mapped to chromosome 17q12–21. If this gene is a tumour suppressor gene, allele losses would be expected in the tumours of affected family members and the losses should affect the wild–type chromosome, reflecting the need for inactivation of the wild–type allele at the predisposing locus. In four multiple case breast–ovarian cancer families, we have found that in each of nine tumours which showed allele losses, the losses were from the wild–type chromosome. This suggests that the putative ‘breast–ovarian’ cancer gene is indeed a tumour suppressor gene.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).
Narod, S.A. et al. Familial breast-ovarian cancer locus on chromosome 17q12–q23. Lancet 338, 82–83 (1991).
Ponder, B.A.J. Gene losses in human tumours. Nature 335, 400–401 (1988).
Viskochil, D. et al. Deletions and translocations interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62, 187–192 (1990).
Russell, S.E.H., Hickey, G.I., Lowry, W.S., White, P. & Atkinson, R.J. Allele loss from chromosome 17 in ovarian cancer. Oncogene 5, 1581–1583 (1990).
Eccles, D.M., Cranston, G., Steel, C.M., Nakamura, Y. & Leonard, R.C.F. Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene 5, 1599–1601 (1990).
Futreal, P.A. et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res. 52, 2624–2627 (1992).
Steeg, P.S. et al. Evidence for a novel gene associated with low tumour metastatic potential. J. natn. Cancer Inst. 80, 200–204 (1988).
Rosengard, A.M. et al. Reduced NM23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 342, 177–180 (1989).
Sato, T. et al. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res. 52, 1643–1646 (1992).
Weber, J.L. et al. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucl. Acids Res. 18, 4640 (1990).
Hall, J.M. et al. Closing in on the breast cancer gene on chromosome 17q. Am. J. hum. Genet. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, S., Easton, D., Evans, D. et al. Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome. Nat Genet 2, 128–131 (1992). https://doi.org/10.1038/ng1092-128
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1092-128
- Springer Nature America, Inc.
This article is cited by
-
The deubiquitinating enzyme USP4 regulates BRCA1 stability and function
npj Breast Cancer (2024)
-
Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells
Nature Biomedical Engineering (2023)
-
A BRCA1 Splice Site Variant Responsible for Familial Ovarian Cancer in a Han-Chinese Family
Current Medical Science (2022)
-
Fertility preservation in BRCA mutation carriers—efficacy and safety issues: a review
Reproductive Biology and Endocrinology (2020)
-
BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan
Scientific Reports (2020)